500,000 healthcare jobs added because of ACA

A new analysis from Goldman Sachs said that 500,000 of the jobs added to the healthcare sector since 2012 can be attributed to the Affordable Care Act (ACA)’s increasing of health insurance coverage.

The ACA has been credited with dropping the uninsured rate to its lowest level ever, hitting 8.8 percent through the first nine months of 2016, while simultaneously accelerating the spread of narrow networks and high-deductible health plans.

The nationwide increase in insurance coverage explained about 40 percent of the sector’s overall job growth in the past five years, according to Goldman. Based on its projection, for every 1 percentage point increase in insurance coverage, there was an associated increase in healthcare employment and healthcare consumption of 0.6 of a percentage point.

Those gains in coverage could be erased by a variety of plans to repeal and replace the ACA, and in turn reverse the increased employment.

“Substantial decline in insurance coverage would also likely be associated with a drag on health care employment and health care consumption,” the report said.

A January 2017 report from the Commonwealth Fund estimated the employment gains could be erased and then some depending on what parts of the law are changed. If both subsidies for buying health insurance and the expanded eligibility for Medicaid are eliminated, more than 1 million healthcare jobs could be lost by 2023.

Estimated losses were smaller if only the subsidies were axed (369,000 healthcare jobs would be lost in 2019) or if the Medicaid expansion were rolled back on its own (543,000 healthcare jobs).  

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup